Natera has acquired liquid biopsy startup Foresight Diagnostics in a deal valued at up to $450 million, strengthening its push into ultra-sensitive molecular residual disease (MRD) detection, particularly in lymphoma. The all-stock transaction includes $275 million upfront and up to $175 million tied to future…
A new study has intensified scrutiny of UnitedHealth Group’s vertical integration strategy, alleging that UnitedHealthcare pays its sister company, Optum,…
A new round of data breaches has struck multiple healthcare entities — from specialty clinics to a national RCM firm…
Together with 20 physician specialty organizations, AGA sent a letter to the Center for Consumer Information and Insurance Oversight to…
The expiration of Medicare telehealth coverage on Sept. 30 has forced providers to cancel or shift appointments, leaving millions of…
Thought Leadership
Multi-cancer early detection blood tests, designed to identify cancer signals from a single blood draw, are rapidly gaining interest from patients, employers, and health…
Facing rising labor costs, payer compression, and administrative drag, GI Partners of…
Bariatric care is entering a new era. As endoscopic weight-loss procedures become…
At DDW 2025, Thomas Imperiale, MD, laid out a reality the GI…
ARTIFICIAL INTELLIGENCE (AI)
Tech & Innovation
New York Gastroenterology Associates, one of the city’s largest independent GI practices, is moving pathology fully into the digital era by adopting Proscia’s AI-enabled Concentriq platform.…
Exponential Tech
New York Gastroenterology Associates, one of the city’s largest independent GI practices,…
Leadership
The U.S. gastroenterologist shortage is no longer a temporary staffing problem—it’s a…